You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • SAT0271 Continued Improvement of Signs and Symptoms in Ustekinumab-Treated Patients with Active Psoriatic Arthritis: Week 52 Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Psoriatic arthritis
SAT0271 Continued Improvement of Signs and Symptoms in Ustekinumab-Treated Patients with Active Psoriatic Arthritis: Week 52 Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 20141501
Mar 20141500
Apr 2014200
May 20141901
Jun 2014500
Jul 2014400
Aug 2014300
Sep 2014300
Oct 2014901
Nov 20141703
Dec 2014300
Jan 2015500
Feb 2015400
Mar 20151501
Apr 2015500
May 2015100
Jun 2015201
Jul 2015701
Aug 2015500
Sep 2015600
Oct 2015600
Nov 2015702
Dec 2015701
Jan 20161000
Feb 2016100
Mar 2016300
Apr 2016901
May 2016700
Jun 2016900
Jul 20161701
Aug 2016803
Sep 2016701
Oct 2016500
Nov 2016501
Dec 2016600
Jan 2017500
Feb 2017100
Mar 2017702
Apr 2017502
May 2017500
Jun 20171402
Jul 2017400
Aug 20171800
Sep 20171401
Oct 2017800
Nov 2017600
Dec 20171200
Jan 2018800
Feb 2018400
Mar 2018600
Apr 2018600
May 2018800
Jun 20181003
Jul 2018600
Aug 2018600
Sep 20181200
Oct 2018600
Nov 2018600
Jan 2019400
Mar 2019200
Apr 2019800
May 2019200
Sep 2019201
Oct 2019900
Nov 2019500
Dec 2019200
Jan 2020801
Feb 2020200
Apr 2020601
May 2020200
Jun 2020100
Jul 2020200
Aug 2020300
Sep 2020900
Oct 2020300
Nov 2020500
Dec 2020400
Jan 2021400
Feb 20212300
Mar 2021500
Apr 2021100
May 2021400
Jul 2021100
Aug 2021200
Oct 20211400
Dec 2021700
Jan 2022900
Feb 2022200
Mar 2022600
May 2022400
Jul 20222000
Aug 2022200
Sep 2022400
Oct 2022200
Nov 2022500
Dec 2022400
Jan 20233000
Feb 2023300
Mar 20232200
May 2023200
Jul 2023200
Sep 2023600
Oct 2023300
Nov 2023600
Dec 2023600
Jan 2024400
Feb 20241200
Mar 2024300
Total726032